Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cipher Pharmaceuticals Inc
T.CPH
Alternate Symbol(s):
CPHRF
Healthcare
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology...
products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(3214)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Sep 08, 2021 7:41am
Renewal of Normal Course Issuer Bid
OAKVILLE, ON, Sept. 8, 2021 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or the "Company") announced today that it has filed, and the Toronto Stock
...more
(11)
•••
stockfy
X
View Profile
View Bullboard History
Comment by
stockfy
on Aug 29, 2021 11:02am
RE:RE:Healthcare picks: After CPH, I pick Viemed (VMD)
With CPH at C$2.23, does Justin Keywood still have a job in Stifel?
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(164)
•••
Northforce13
X
View Profile
View Bullboard History
Post by
Northforce13
on Aug 24, 2021 10:35pm
MOB - 015, other products
Anyone in the community have any ideas as to answers on; When will MOB - 015 likely be released in the USA/Canada, have they said anything time line wise that I missed? Their annual information
...more
(3522)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Aug 24, 2021 8:26am
Peer Based Price to Book
The current value is 6.7 times book..see link below. Current Book value is $47 million cad. At current Price to book valuation multiupole of 6.7 , the fair market cap valuation is $315 million
...more
(3522)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Aug 23, 2021 8:01am
Peer Based Proxy Valuation.. $10 + CAD per share
EV = M Cap + debt - Cash =$25 m cad Ebitda = $4.1 m US x 4 X 1.25 = $20 million cad Ev to Ebitda valuation Multiple 14.40 for Biotech 14.32 for Pharm Average is 14.36 times So we have
...more
(3522)
•••
nozzpack
X
View Profile
View Bullboard History
Comment by
nozzpack
on Aug 20, 2021 12:51pm
RE:New multi-year high and insider buy
Loving it. I will go much higher than this..
(3522)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Aug 18, 2021 9:43am
Block Trades
Nice to see cheap paper being taken out.
(164)
•••
Northforce13
X
View Profile
View Bullboard History
Post by
Northforce13
on Aug 17, 2021 12:19pm
Q2
Wow... didn't bother posting, the results spoke for themselves. My model had their revenues and net income contracting steadily. To see the results so different was somewhat shocking.
...more
(471)
•••
microcaphobby
X
View Profile
View Bullboard History
Post by
microcaphobby
on Aug 13, 2021 11:02am
new coverage coming?
a guy from Leede, Jones Gable was on the call and asked a question.
(471)
•••
microcaphobby
X
View Profile
View Bullboard History
Post by
microcaphobby
on Aug 13, 2021 11:00am
conference call nugget
They show taxes payable in the q but in fact they have losses that will offset all of thoat tax liability. ie 1 mill of taxes will disappear so net income in fact 3 cents higher US Mull has
...more
(3522)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Aug 13, 2021 9:49am
Near Blowout Quarter
Q2 2021 financial highlights (all figures in U.S. dollars, compared with Q2 2020, unless otherwise noted): Total revenue increased 30 per cent to $6.1-million compared with $4.7-million;
...more
(1)
•••
maxxie3
X
View Profile
View Bullboard History
Post by
maxxie3
on Aug 12, 2021 6:19pm
AND NO IMPAIRMENT CHARGES..
(3522)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Aug 10, 2021 2:48pm
Suns New Acme Drug In Canada and US
How will this affect Cipher's acme sales and royalies https://www.bloombergquint.com/business/sun-pharma-gets-exclusive-right-to-market-cassiopeas-acne-drug-in-us-canada
(11)
•••
stockfy
X
View Profile
View Bullboard History
Comment by
stockfy
on Jun 19, 2021 1:06pm
RE:Healthcare picks: After CPH, I pick Viemed (VMD)
Does Justin Keywood still have a job in Stifel?
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden